Effect of Thyroid Function on MNU-Induced Mammary Carcinogenesis

Area of Science:

• Endocrinology
• Oncology
• Experimental Pathology

Background:

• Thyroid hormones, thyroxine and 3,3',5-triiodothyronine, regulate cellular processes in mammary tissue.
• Thyroid hormones influence mammary cancer cell growth, potentially via estrogen receptor pathways.
• Understanding thyroid function's role in mammary cancer is crucial for identifying new therapeutic targets.

Purpose of the Study:

• To investigate the effect of induced hyperthyroidism and hypothyroidism on mammary tumor development in rats.
• To determine if thyroid hormone levels influence mammary tumor multiplicity, prevalence, and burden.
• To explore the relationship between thyroid status and mammary cancer cell growth.

Main Methods:

• Female Sprague-Dawley rats were divided into euthyroid, hyperthyroid (levothyroxine), and hypothyroid (thyroidectomy) groups.
• Mammary carcinogenesis was induced using N-methyl-N-nitrosurea (MNU).
• Tumor burden, malignancy, and estrogen receptor (ER) expression were analyzed at 38 weeks.

Main Results:

• The hyperthyroid group exhibited a significantly higher mammary tumor burden compared to the euthyroid control group.
• The hypothyroid group showed no mammary tumors of tissue origin at the study's conclusion.
• All analyzed mammary tumors were estrogen receptor alpha negative.

Conclusions:

• Thyroid hormone status is a significant modulator of N-methyl-N-nitrosurea-induced mammary tumor growth in rats.
• Hyperthyroidism promotes mammary tumor development, whereas hypothyroidism appears protective.
• These findings highlight thyroid function as a key factor in mammary cancer modulation.